Correction to: Mesenchymal stem cells in the treatment of severe COVID-19
Transl Med Commun
.
2021;6(1):19.
doi: 10.1186/s41231-021-00098-x.
Epub 2021 Aug 23.
Authors
Santosh Kesari
1
,
Gregory C Kasper
2
,
Lev Verkh
3
,
Terese C Hammond
4
,
Marla L Matal
2
,
Jay W Hammerling
2
,
Nikolai Tankovich
3
,
Adrianus P Lim
2
,
Kevin H Zhao
2
,
Tiffany Juarez
1
,
Roberta E Redfern
2
,
Jaya M Gill
5
,
Natsuko Nomura
1
,
Audrey Hiemer
1
,
Annie Heng
1
,
Jessica Shoemaker
2
Affiliations
1
Pacific Neuroscience Institute and Providence Saint John's Health Center, Santa Monica, USA.
2
ProMedica Toledo Hospital, 2142 North Cove Blvd, Toledo, OH 43606 USA.
3
Stemedica Cell Technologies, Inc., San Diego, USA.
4
Providence Saint John's Health Center, Santa Monica, USA.
5
Pacific Neuroscience Institute, Santa Monica, USA.
PMID:
34458585
PMCID:
PMC8381133
DOI:
10.1186/s41231-021-00098-x
Abstract
[This corrects the article DOI: 10.1186/s41231-021-00095-0.].
© The Author(s) 2021.
Publication types
Published Erratum